Thursday, September 20, 2018 Daily Archives

Lonza targets both early and late-stage biotech in $415m Ibex expansion

by

CDMO Lonza has invested CHF 400 million in a site in Switzerland to expand its Ibex Solutions business, adding end-to-end services for biotech customers. Contract development and manufacturing organization (CDMO) Lonza has launched today Ibex Design and Ibex Develop, offering smaller biopharma companies complete product lifecycle management. The CHF 400 million ($415 million) expansion follows the launch of the Ibex Solutions service in July 2017, which saw the firm look to provide flexible production capacity for biotherapeutics through a biopark…

September 20, 2018

Prefab sprouts in China as BeiGene selects GE for MAb facility

by

Much of Asia lacks traditional biomanufacturing infrastructure according to GE Healthcare, which says prefabricated facilities like its KUBio platform can support the rapid biologics growth in the region. BeiGene Ltd inked a deal with GE Healthcare in 2015 to install the bioprocessing vendor’s FlexFactory platform at its clinical monoclonal antibody facility in Suzhou, China. Three years on and the Chinese biotech firm has chosen GE Healthcare’s prefabricated biomanufacturing facility offering KUBio for commercial production of cancer MAbs at a site…

September 20, 2018